FDA Approves Ocular Implant for Vision-Threatening MacTel

(MedPage Today) -- The FDA approved revakinagene taroretcel (Encelto) as the first treatment for adults with idiopathic macular telangiectasia (MacTel) type 2, Neurotech Pharmaceuticals announced on Thursday.
A rare, progressive neurodegenerative...